Dr No émi Roy Oxford Molecular Haematology What is the research agenda This is the topics that funding bodies accept as being reasonable valid and worthy of funding in each field It is partly dictated by researchers own interests intellectual drug companies interests finan ID: 651990
Download Presentation The PPT/PDF document "Patient and public involvement (PPI) in ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Patient and public involvement (PPI) in setting the research agenda
Dr
No
émi
Roy
Oxford Molecular
HaematologySlide2
What is the research agenda?
This is the topics that funding bodies accept as being reasonable, valid and worthy of funding in each field
It is partly dictated by researchers’ own interests (intellectual), drug companies’ interests (financial!) and to a certain extent some political guidance (
eg
Government putting extra funding into dementia research)Slide3
Why should patients be involved?
Ethical reasons: democracy, accountability, empowerment
Because patients are the ultimate beneficiaries of the research, involving them in setting the topics increases the
RELEVANCE
, the
VALIDITY
and the
QUALITY
of the researchSlide4
How can patients be involved?
This can de done through a PSP (priority setting partnership), which brings together patients/
carers
and clinicians in a structured way (
eg
through a JLA partnership- see later)
A list of “top 10 topics” is created at the end of the PSPSlide5
Does this actually make a difference?
More and more, funding bodies will look at the topics selected by a PSP and if a research proposal is asking for money and the topic is not one of the “Top 10” chosen by the PSP, it will be very difficult for it to get funded.
This ensures the “Top 10” topics really do get money channeled to themSlide6
What is the JLA?
This is the James Lind Alliance.
What the JLA does:
The JLA facilitates Priority Setting Partnerships. These bring patients,
carers
and clinicians together to identify and
prioritise
for research the treatment uncertainties which they agree are the most important. The JLA believes that:
addressing uncertainties about the effects of treatments should become accepted as a much more routine part of clinical practice
patients,
carers
and clinicians should work together to agree which, among those uncertainties, matter most and thus deserve priority attentionSlide7
(Out of interest, who was James Lind??)
Who was James Lind:
The James Lind Alliance (JLA) is named after a pioneer of clinical trials, James Lind. Two hundred and fifty years ago, there were many conflicting ideas and unanswered questions about how to treat the deadly disease scurvy. James Lind – a Scottish naval surgeon – decided to confront this uncertainty by treating his patients within a clinical trial comparing six of the proposed remedies. His trial showed that oranges and lemons were dramatically better than the other supposed treatments. Slide8
How long does it take?
The time scale for a Priority Setting Partnership will vary depending on scope and resources. Normally the process will usually take between 12 and 18 months to complete.Slide9
What about rare anaemias?
We in Oxford are setting up a JLA PSP to try to identify the top 10 priorities for patients with rare inherited
anaemias
, and the clinicians looking after them
We will work with clinicians all over the UK, and with as many patient groups as are willing to get on boardSlide10
How does it work?
The Priority Setting Partnership is led by a steering group. This has clinicians and patient representatives on it.
Using the JLA’s guidance, the groups sets out how it will collect the data- paper surveys, online forms, face-to-face workshops,
etc
After the surveys have been filled in and the workshops completed, all of the data is looked at by the data handlerSlide11
How does it work?
The data handler looks at all the responses and groups similar responses together into different questions
Once all the different questions are clearly set out, patient representatives and clinicians together agree on the “Top Ten” questions that they feel research should focus on
The steering committee
publicises
the results to funding bodies and participantsSlide12
What about DBA UK?
You are the largest support group of any type of inherited
anaemias
in the UK
You have an excellent track record of interest in research and patient advocacy
You are very
organised
and have regular activities with your membersSlide13
Now what?
We would be interested in:
Having someone from your Committee on our PSP Steering Committee
Talking to your members at the Family Weekend about PPI and the JLA partnership we are setting up
Sending the surveys to your members
Holding workshops with some of your members (
eg
at the adult meeting)Slide14
Any questions?
Please don’t hesitate to contact me:
noemi@romahi.com